The briefing
A cohort study found that receiving a COVID‑19 mRNA vaccine within 90 days of starting anti–PD-(L)1 therapy was associated with improved overall survival in cancer patients. Researchers note the findings are observational and warrant further investigation.
Original headline
Concomitant COVID-19 Vaccination Tied to Improved OS with Immunotherapy